Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

DNA-Constructed Nanoparticles Safely Target Tumors

By BiotechDaily International staff writers
Posted on 17 Feb 2014
A team of Canadian researchers has discovered a way to assemble “building blocks” of gold nanoparticles as the vehicle to deliver cancer medications or cancer-identifying markers directly into cancerous tumors.

The study, led by Prof. Warren Chan, of University of Institute of Biomaterials & Biomedical Engineering (IBBME; ON, Canada) and the Donnelly Center for Cellular & Biomolecular Research, was published February 2014 in the journal Nature Nanotechnology.

“To get materials into a tumor they need to be a certain size,” explained Prof. Chan. “Tumors are characterized by leaky vessels with holes roughly 50–500 nm in size, depending on the tumor type and stage. The goal is to deliver particles small enough to get through the holes and ‘hang out’ in the tumor’s space for the particles to treat or image the cancer. If particle is too large, it can’t get in, but if the particle is too small, it leaves the tumor very quickly.”

Prof. Chan and his researchers solved this problem by creating modular structures “glued” together with DNA. “We’re using a ‘molecular assembly’ model—taking pieces of materials that we can now fabricate accurately and organizing them into precise architectures, like putting LEGO blocks together,” said Leo Chou, a fifth-year PhD, student at IBBME and first author of the paper. “The major advantage of this design strategy is that it is highly modular, which allows you to ‘swap’ components in and out,” he said. “This makes it very easy to create systems with multiple functions, or screen a large library of nanostructures for desirable biological behaviors."

The long-term risk of toxicity from particles that linger in the body, however, has been a serious hurdle to nanomedical research. “Imagine you’re a cancer patient in your 30s,” said Prof. Chan. “And you’ve had multiple injections of these metal particles. By the time you’re in your mid-40s these are likely to be retained in your system and could potentially cause other problems.”

Although DNA is flexible, and over time, the body’s natural enzymes cause the DNA to degrade, and the grouping breaks apart. The body then eliminates the smaller particles safely and easily. But while the researchers are excited about this breakthrough, Prof. Chan stressed that a lot more details need to be determined. “We need to understand how DNA design influences the stability of things, and how a lack of stability might be helpful or not,” he said. “The use of assembly to build complex and smart nanotechnology for cancer applications is still in the very primitive stage of development. Still, it is very exciting to be able to see and test the different nanoconfigurations for cancer applications.”

Related Links:
University of Toronto’s Institute of Biomaterials & Biomedical Engineering



comments powered by Disqus

Channels

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.